DNTH
Dianthus Therapeutics Inc.
85.40$
-3.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 162.0% | -2,593.9% | -1,709.5% | -779.8% | -979.1% | -2,069.7% | -2,375.8% | -12,379.3% | -7,715.9% | -16,543.3% | -6,232.4% | -6,436.4% | -8,160.5% | |
| 2.1% | 22.5% | 12.2% | 6.0% | 5.3% | 5.9% | 11.4% | 51.3% | 25.0% | 34.2% | 16.4% | -0.9% | 13.9% | |
| 127.6% | 158.9% | 232.8% | 166.5% | 176.8% | 295.5% | 457.0% | 2,956.5% | 1,463.1% | 2,104.9% | 2,289.8% | 1,563.5% | 1,800.0% | |
| 1,123.9% | -348.6% | -322.3% | 15.5% | 119.7% | -31.8% | -143.0% | 1,581.3% | 721.0% | 4,395.1% | 478.6% | -658.6% | 658.7% | |
| 15.7% | 2.2% | 3.7% | 0.9% | 1.2% | 2.3% | 2.1% | 23.8% | 1.3% | 48.6% | 2.2% | 23.8% | 17.5% | |
| -1,826.8% | -1,802.4% | -630.1% | 62.7% | -11,941.3% | -1,742.8% | 1,272.1% | 13,702.1% | -50,827.0% | 13,099.6% | -28,935.9% | -62,880.0% | -40,785.8% | |
| – | – | – | – | -2,288.4% | – | – | – | – | 111.6% | 25.9% | – | – | |
| – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 16,675.1% | -1,064.6% | 24,925.3% | -117.9% | 13.6% | 2,992.2% | 13.8% | 294.3% | 69,321.5% | 1,719.4% | 159,699.8% | 1,364.0% | 54,053.9% | |
| 10,243.4% | -5,460.8% | 22,585.7% | -834.9% | -12,914.3% | -820.4% | -1,089.9% | 1,617.1% | 10,778.5% | -1,724.3% | 124,531.5% | -67,952.4% | 5,107.6% | |
| 177.7% | -2,596.1% | -1,713.2% | -780.7% | -980.3% | -2,072.0% | -2,377.8% | -12,403.1% | -7,717.2% | -16,591.9% | -6,234.6% | -6,460.2% | -8,178.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.